Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 14.18
-0.29 (-2.00%)
Apr 21, 2026, 3:00 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 5.74 billion as of April 21, 2026. Its market cap has decreased by -6.65% in one year.
Market Cap
5.74B
Enterprise Value
4.21B
Revenue
2.26B
Ranking
n/a
PE Ratio
35.47
Stock Price
14.18
Market Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 5.74B, a decrease of -47.62%. That is a compound annual growth rate of -12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 5.74B | 6.78% |
| Dec 31, 2025 | 5.38B | 6.24% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 6.50B |
| Lifecome Biochemistry | 6.31B |
| Kexing Biopharm | 6.27B |
| Shenzhen Weiguang Biological Products | 6.21B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.14B |
| Beijing Konruns Pharmaceutical | 6.14B |
| Innovita Biological Technology | 5.85B |
| Wuhan Hvsen Biotechnology | 5.68B |